A detailed history of Ieq Capital, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ieq Capital, LLC holds 88,370 shares of TAK stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,370
Previous 41,502 112.93%
Holding current value
$1.26 Million
Previous $641,000 101.72%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$13.6 - $15.52 $637,404 - $727,391
46,868 Added 112.93%
88,370 $1.29 Million
Q2 2025

Aug 14, 2025

BUY
$13.71 - $15.46 $264,328 - $298,068
19,280 Added 86.76%
41,502 $641,000
Q1 2025

May 14, 2025

BUY
$12.89 - $15.19 $12,645 - $14,901
981 Added 4.62%
22,222 $330,000
Q4 2024

Jan 31, 2025

BUY
$13.01 - $14.43 $128,460 - $142,481
9,874 Added 86.87%
21,241 $281,000
Q3 2024

Nov 14, 2024

BUY
$13.0 - $15.08 $5,694 - $6,605
438 Added 4.01%
11,367 $161,000
Q2 2024

Aug 12, 2024

BUY
$12.6 - $13.67 $137,705 - $149,399
10,929 New
10,929 $141,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.